Study Title: Prospective, Longitudinal, Non-Interventional Study of Disease Burden and Treatment of Patients with Low-Risk Myelofibrosis (MF) or High-Risk Essential Thrombocythemia (ET) or ET Patients Receiving ET-Directed Therapy (MOST)

Study Summary

The purpose of this prospective, longitudinal, noninterventional study is to describe clinical characteristics, evolution of disease burden, and treatment patterns in patients with select subcategories of essential thrombocythemia (ET) or myelofibrosis (MF).

Principal Investigator: Myron Bednar, MD

PhaseI V

Study Website

If you have any questions regarding this study or think that you or your loved one may be eligible, please feel free to contact:  Julianne Wilson, MSN @ 908-237-2330 ex 2

Menu